Literature DB >> 2886483

Isolation of Clostridium perfringens from neonatal calves with ruminal and abomasal tympany, abomasitis, and abomasal ulceration.

B L Roeder, M M Chengappa, T G Nagaraja, T B Avery, G A Kennedy.   

Abstract

Eight neonatal calves (2 to 21 days old) with suspected abomasal displacement or intestinal obstruction after acute onset of abdominal tympany, colic, depression, or death were referred to Kansas State University for clinical examination or for necropsy. Results of routine hematologic and serum chemical analyses did not reveal consistent changes. Necropsy revealed abomasal distention, with various degrees of abomasitis, hemorrhage, and ulceration, but did not reveal evidence of displaced abomasum or obstructed intestine. Specimens of ruminal contents collected via stomach tube or at necropsy and abomasal contents collected at necropsy were obtained for anaerobic bacteriologic culture. Clostridium perfringens was isolated from all specimens, and on the basis of toxin neutralization tests in mice, 7 were type A and one was type E. Copper concentrations in serum and tissues were within normal limits. It appeared that the acute abdominal syndrome in these neonatal calves was unrelated to copper deficiency, and that C perfringens, particularly type A, may have had an appreciable contributory role in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886483

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  12 in total

Review 1.  Differentiation of gastrointestinal diseases of calves.

Authors:  C B Navarre; E B Belknap; S E Rowe
Journal:  Vet Clin North Am Food Anim Pract       Date:  2000-03       Impact factor: 3.357

2.  Clostridial abomasal disease in Connecticut dairy calves.

Authors:  Herbert J Van Kruiningen; Carol A Nyaoke; Inga F Sidor; Jaroslaw J Fabis; Lynn S Hinckley; Kevin A Lindell
Journal:  Can Vet J       Date:  2009-08       Impact factor: 1.008

3.  Determination of the effect of single abomasal or jejunal inoculation of Clostridium perfringens type A in dairy cows.

Authors:  Jennifer M Ewoldt; David E Anderson
Journal:  Can Vet J       Date:  2005-09       Impact factor: 1.008

4.  Enteritis associated with Clostridium perfringens type A in 9-month-old calves.

Authors:  Bozidar Savic; Radisa Prodanovic; Vojin Ivetic; Oliver Radanovic; Jovan Bojkovski
Journal:  Can Vet J       Date:  2012-02       Impact factor: 1.008

5.  Metagenome plasticity of the bovine abomasal microbiota in immune animals in response to Ostertagia ostertagi infection.

Authors:  Robert W Li; Sitao Wu; Weizhong Li; Ying Huang; Louis C Gasbarre
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

6.  Genome sequencing and analysis of a type A Clostridium perfringens isolate from a case of bovine clostridial abomasitis.

Authors:  Victoria J Nowell; Andrew M Kropinski; J Glenn Songer; Janet I MacInnes; Valeria R Parreira; John F Prescott
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

7.  The effect of helminth infection on the microbial composition and structure of the caprine abomasal microbiome.

Authors:  Robert W Li; Weizhong Li; Jiajie Sun; Peng Yu; Ransom L Baldwin; Joseph F Urban
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

Review 8.  Rethinking the role of alpha toxin in Clostridium perfringens-associated enteric diseases: a review on bovine necro-haemorrhagic enteritis.

Authors:  Evy Goossens; Bonnie R Valgaeren; Bart Pardon; Freddy Haesebrouck; Richard Ducatelle; Piet R Deprez; Filip Van Immerseel
Journal:  Vet Res       Date:  2017-02-16       Impact factor: 3.683

9.  Clostridial abomasitis in calves: case report and review of the literature.

Authors:  J Glenn Songer; Dale W Miskimins
Journal:  Anaerobe       Date:  2005-04-25       Impact factor: 3.331

10.  Clostridium Perfringens Toxins Involved in Mammalian Veterinary Diseases.

Authors:  F A Uzal; J E Vidal; B A McClane; A A Gurjar
Journal:  Open Toxinology J       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.